Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler Jack Padovano - Stifel Operator Good afternoon, and welcome to Supernus Pharmaceuticals' First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator I ...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Peter Vozzo - Westwicke-Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler Jack Padovano - Stifel Operator Good afternoon, and welcome to Supernus Pharmaceuticals' Preliminary Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this ti ...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2021 Earnings Conference Call November 3, 2021 4:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies Ken Cacciatore - Cowen David Amsellem - Piper Sandler Annabel Samimy - Stifel Operator Good afternoon, and welcome to Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call [Operator Inst ...

Adamas Pharmaceuticals, Inc. (ADMS) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Peter Vozzo - Investor Relations Neil McFarlane - Chief Executive Officer Vijay Shreedhar - Chief Commercial Officer Chris Prentiss - Chief Financial Officer Adrian Quartel - Chief Medical Officer Conference Call Participants Jason Butler - JMP Securities Ken Cacciatore - Cowen Marc Goodman - SVB Leerink David Amsellem - Piper Sandler Operator Greetings and welcome to the Adamas Pharmaceutical ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases May, 10 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements c ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases May, 10 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements c ...

Adamas Pharmaceuticals, Inc. (ADMS) Q1 2021 Earnings Conference Call May 10, 2021 4:30 PM ET Company Participants Peter Vozzo – Investor Relations Neil McFarlane – Chief Executive Officer Vijay Shreedhar – Chief Commercial Officer Chris Prentiss – Chief Financial Officer Adrian Quartel – Chief Medical Officer Conference Call Participants Marc Goodman – SVB Leerink Lachlan Hanbury-Brown – William Blair Jason Butler – JMP Securities Stacy Ku – Cowen & Co. Zack Sachar – Piper Sandler Operator Welcome to the Ad ...

| --- | --- | |------------------------------------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. Corporate Overview April 2021 | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, relate to Sup ...

Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases MARCH 2, 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements 2 › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements ...

| --- | --- | |------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals Corporate Overview February 2021 | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, relate to Supernus' business strategy, g ...